These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2270998)

  • 1. Women's knowledge of Papanicolaou smears.
    Gordon IL; Fatovich BS
    Aust Fam Physician; 1990 Nov; 19(11):1739, 1742-5, 1749-50. PubMed ID: 2270998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Women's attitudes to and awareness of smear testing and cervical cancer.
    Yu CK; Rymer J
    Br J Fam Plann; 1998 Jan; 23(4):127-33. PubMed ID: 9882766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Have the most recent Pap smear guidelines affected GP practices?
    Wai D; Ferrier A; Collings S; Laverty C
    Aust Fam Physician; 1996 Jan; Suppl 1():S44-8. PubMed ID: 9479800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women.
    Bakemeier RF; Krebs LU; Murphy JR; Shen Z; Ryals T
    J Natl Cancer Inst Monogr; 1995; (18):95-100. PubMed ID: 8562228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women at risk: papanicolaou smear screening in Florida.
    Vincent AL; Greene JN; Hoercherl S; McTague D
    J Fla Med Assoc; 1997; 84(5):302-7. PubMed ID: 9260433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician recommendation for papanicolaou testing among U.S. women, 2000.
    Coughlin SS; Breslau ES; Thompson T; Benard VB
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1143-8. PubMed ID: 15894664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintaining uterine health. Papanicolaou smear screening through the generations.
    Simms-Cendan JS
    J Fla Med Assoc; 1996; 83(7):470-2. PubMed ID: 8824088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Australian women's needs and preferences for information about human papillomavirus in cervical screening.
    McCaffery K; Irwig L
    J Med Screen; 2005; 12(3):134-41. PubMed ID: 16156944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women's health: early detection and screening practices for breast and cervical cancer.
    Thomas SM; Fick AC
    J La State Med Soc; 1994 Apr; 146(4):152-8. PubMed ID: 8006498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jordanian women's attitudes towards cervical screening and cervical cancer.
    Maaita M; Barakat M
    J Obstet Gynaecol; 2002 Jul; 22(4):421-2. PubMed ID: 12521469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer risk and Papanicolaou screening in a sample of lesbian and bisexual women.
    Rankow EJ; Tessaro I
    J Fam Pract; 1998 Aug; 47(2):139-43. PubMed ID: 9722802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge and participation of general practitioners in cervical cancer screening: survey in a French pilot area.
    Monnet E; Mauny F; Marquant A; Michaud C; Ferry JP
    Rev Epidemiol Sante Publique; 1998 Mar; 46(2):108-14. PubMed ID: 9592853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of Pap smear screening of high risk aboriginal women. Use of a computerised process tool within the Broome Aboriginal Medical Service.
    Couzos S; Wronski I; Murray R; Cox H
    Aust Fam Physician; 1998 Apr; 27(4):269-74. PubMed ID: 9581335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a cognition-emotion focused program to increase public participation in Papanicolaou smear screening.
    Park S; Chang S; Chung C
    Public Health Nurs; 2005; 22(4):289-98. PubMed ID: 16150010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addressing Taiwan's high incidence of cervical cancer: factors associated with the Nation's low compliance with Papanicolaou screening in Taiwan.
    Liao CC; Wang HY; Lin RS; Hsieh CY; Sung FC
    Public Health; 2006 Dec; 120(12):1170-6. PubMed ID: 17074376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening.
    Papa D; Moore Simas TA; Reynolds M; Melnitsky H
    J Low Genit Tract Dis; 2009 Apr; 13(2):66-71. PubMed ID: 19387125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
    Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
    Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of intent to seek unnecessary pap tests among elderly women.
    Zhang Y; Borders TF; Rohrer JE
    Womens Health Issues; 2007; 17(6):351-9. PubMed ID: 17936642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women's compliance with public health guidelines for mammograms and pap tests in Canada and the United States: an analysis of data from the Joint Canada/United States Survey Of Health.
    Blackwell DL; Martinez ME; Gentleman JF
    Womens Health Issues; 2008; 18(2):85-99. PubMed ID: 18182305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.